Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 434

2.

An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction.

Giammusso B, Colpi GM, Cormio L, Ludovico G, Soli M, Ponchietti R, Montorsi F, Panzironi C, Guastella B.

Urol Int. 2008;81(4):409-15. doi: 10.1159/000167838.

PMID:
19077401
4.

Prospective, randomized, crossover comparison of sublingual apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunction.

Pavone C, Curto F, Anello G, Serretta V, Almasio PL, Pavone-Macaluso M.

J Urol. 2004 Dec;172(6 Pt 1):2347-9.

PMID:
15538264
5.

A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction.

Meuleman E, Cuzin B, Opsomer RJ, Hartmann U, Bailey MJ, Maytom MC, Smith MD, Osterloh IH.

BJU Int. 2001 Jan;87(1):75-81.

7.

A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction.

Perimenis P, Gyftopoulos K, Giannitsas K, Markou SA, Tsota I, Chrysanthopoulou A, Athanasopoulos A, Barbalias G.

Int J Impot Res. 2004 Feb;16(1):2-7.

PMID:
14963464
8.

Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.

Afif-Abdo J, Teloken C, Damião R, Koff W, Wroclawski E, Yamasaki R, Torres LO, Sabaneeff J, Faria G, Pompeo AC, Cortado P, Glina S.

BJU Int. 2008 Sep;102(7):829-34. doi: 10.1111/j.1464-410X.2008.07767.x.

9.

Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction.

Buvat J, Hatzichristou D, Maggi M, Farmer I, Martínez-Jabaloyas JM, Miller PJ, Schnetzler G.

BJU Int. 2008 Dec;102(11):1645-50. doi: 10.1111/j.1464-410X.2008.07908.x.

10.

Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial.

Fava M, Nurnberg HG, Seidman SN, Holloway W, Nicholas S, Tseng LJ, Stecher VJ.

J Clin Psychiatry. 2006 Feb;67(2):240-6.

PMID:
16566619
11.
12.

Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.

Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, Kopernicky V.

Eur Urol. 2004 Sep;46(3):362-9; discussion 369.

PMID:
15306109
13.

Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial.

Carson CC, Hatzichristou DG, Carrier S, Lording D, Lyngdorf P, Aliotta P, Auerbach S, Murdock M, Wilkins HJ, McBride TA, Colopy MW; Patient Response with Vardenafil in Slidenafil Non-Responders (PROVEN) Study Group..

BJU Int. 2004 Dec;94(9):1301-9. Erratum in: BJU Int. 2005 Aug;96(3):466.

14.

Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial.

Pickering TG, Shepherd AM, Puddey I, Glasser DB, Orazem J, Sherman N, Mancia G.

Am J Hypertens. 2004 Dec;17(12 Pt 1):1135-42.

PMID:
15607620
17.

Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra).

Shabsigh R, Padma-Nathan H, Gittleman M, McMurray J, Kaufman J, Goldstein I.

Urology. 2000 Apr;55(4):477-80.

PMID:
10736486
19.
20.

A baseline-controlled, open-label, flexible dose-escalation study to assess the safety and efficacy of sildenafil citrate (Viagra) in patients with erectile dysfunction.

Benchekroun A, Faik M, Benjelloun S, Bennani S, El Mrini M, Smires A.

Int J Impot Res. 2003 Apr;15 Suppl 1:S19-24.

PMID:
12825105
Items per page

Supplemental Content

Support Center